The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

media.springer/m685/springer-static/imag

Clinical and Translational Implications of RET Rearrangements in

Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer

Frontiers Recent progress in targeted therapy for non-small cell

Empire Genomics Interviews With Today's Leading Researchers

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver

医药前沿nature发文：CLIP1-LTK 融合基因-非小细胞肺癌的新治疗靶点

科学家揭示非小细胞肺癌新的驱动因素与药物靶点- 专区- 生物谷

Frontiers Recent progress in targeted therapy for non-small cell

New driver mutations in non-small-cell lung cancer - The Lancet